Internally Funded Research
Hammond Awards

January 1, 2012 – December 31, 2012
Project Title
Safety vs. Success: Perceptions for IVF outcomes from double embryo transfer Tensile strength of 2nd-generation permanent surgical mesh for pelvic organ prolapse: a cadaver study Innovative Method to Personalize Overactive Bladder Therapy (IMPROVE)” Determination of the cost of travel for referral to a gynecologic oncologist in women presenting with ovarian masses The correlation of Progesterone receptor membrane component 1 (PGRMC1) expression and cytotrophoblast cell survival and inflammatory responses Bleeding in Pregnancy, the Clot Thickens: Effects of Heparin on Thrombin-induced Inflammation Frailty: An Outcome Predictor for Elderly Gynecologic Oncology Patients
Serina Floyd
The Estimated Impact of Ambient Air Pollution on Miscarriage Rates in the United States
Hammond Awards

July 1, 2011 - June 30, 2012
Project Title
Role of the Mitochondrial Progesterone Receptor (PR-M) in Progestin-Dependent Growth of Human Fibroids protective effect of progesterone in the setting of preterm birth A Randomized Controlled Trial of Immediate versus Delayed Postpartum Implanon: A Pilot Study The Role of Satiety Proteins in Pregnancy Outcomes and Postpartum Weight Retention Internally Funded Research
Hammond Awards

July 1, 2010 - June 30, 2011
Project Title
Investigation of the Human Fetal Membrane Microbiome Antibiotic Prophylaxis for UTI in Patients Requiring Catheterization After Gynecologic Surgery Obesity and dysfunctional labor; effects of obesity and leptin on uterine contractility Quantifying histological injury in cardiac muscle after myocardial insult ni a transgenic mouse model expressing human mitochondrial progesterone receptor (RP-M) Hammond Awards
January 1, 2011 - December 31, 2011

Project Title
The role of various human chorionic gonadotropin isoforms in corpus luteum progesterone production in ectopic and normal pregnancy G protein-coupled receptor kinase 6 mediated desensitization of the oxytocin receptor and its role in maintenance of pregnancy and preterm labor Growing 3 dimensional fibroids in vitro-a new system to test medical treatments of uterine fibroids Psychosocial Factors related to the use of sacral neuromodulation therapy for the treatment of overactive bladder Targeting The SRC Kinase Cancer-Specific Pathway in Leiomyosarcoma Pharmacokinetics of Ertapenem in the Postpartum Period Ultrasound evaluation of low-lying and marginal placenta previa Obesity and dysfunctional labor, chronic effects of leptin on myometrial phenotype Health seeking behaviors in racially diverse women with urinary incontinence Association of Circulating Mitochondiral DNA Content and Preterm Birth Among Black Mothers Quantifying histological injury in cardiac muscle after myocardial insult in a transgenic mouse model expressing human mitochondrial progesterone receptor (PR-M)

Source: http://obgyn.duke.edu/sites/obgyn.duke.edu/files/Internally_Funded_Research3.12.pdf

Oar rulebook - pharmacuetical services

410-121-0030 Practitioner-Managed Prescription Drug Plan (PMPDP) (1) The Practitioner-Managed Prescription Drug Plan (PMPDP) is a plan that ensures that fee for service clients of the Oregon Health Plan shall have access to the most effective prescription drugs appropriate for their clinical conditions at the best possible price: (a) Licensed health care practitioners (informed by the latest


ex/f rames.php?specid=65623130&ty pedoc=N&ref =N0179056.htmVeuillez lire attentivement cette notice avant d'utiliser ce médicament. Elle contient des informationsimportantes pour votre traitement. Si vous avez d'autres questions, si vous avez un doute, demandez plus d'informations à votre médecin ou àvotre pharmacien. · Gardez cette notice, vous pourriez avoir besoin de la relire.

Copyright © 2010 Health Drug Pdf